The purpose of the Ono Initiative is to support scientist Principal Investigators (“PIs”) with creative ideas in selected scientific research field, Chemical Biology, with the mission of seeking discoveries/solutions and development of high impact science. 

The goals of the Ono Initiative are to: 

• Identify and develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.
• Support academic research and the career development of promising young and established scientists.
• Build strong relationships within the community in order to lead to transformative research aligned with Ono Initiative's interest.

Applicants must meet the following requirements. Letter of Interest (LOI) and final Proposals from applicants not meeting the requirements listed below will not be considered.

• PIs applying must be working at one of the nominating institutions. Nominating institutions might be replaced or added to in subsequent years.  
• The PI must have an MD and/or a PhD degree.
• The PI must be a new applicant to the Ono Initiative, or, if they are returning, have applied over three years ago for a project different from the one they are currently proposing.
• The PI must be a young and/or mid-career scientist (15 years or below of experience from starting independent academic position).
• The PI may not already be engaged in other sponsored research with Ono Pharmaceutical Co., Ltd. and/or grant program with Ono Pharma Foundation.
• The PI may not apply for funding to amplify current work. However, PIs may research a new idea based on prior findings of the PI.

Applications will be assessed, and Awards will be made based upon the following criteria:

• Scientific merit of the research Proposal
• Relevance of proposed research to the mission of the Ono Initiative
  • Significance
  • Innovation
  • Approach
• Technical considerations for the research
• Qualifications and relevant experience of the PI
• Evidence of a suitable research environment

The Ono Pharma Foundation selects all Awardees based upon recommendations of its Scientific Advisory Board (“SAB”), which is comprised of outside experts from the fields of Chemical Biology.